The European Commission has opened a formal investigation into possible anticompetitive conduct by Sanofi for disparaging a competitor’s flu vaccine intended for vulnerable patient groups.
Sanofi’s ‘Efluelda’ and CSL Seqirus’s ‘Fluad’ enhanced flu vaccine are…
Leave a Reply